Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. VI. Future research needs

Renal Failure

Volumn 19, Issue 4, 1997, Pages 575-594

  Finn, William F ^a   Nolan, Canice ^b   Lash, Lawrence H ^c   Lorenzon, Giocondo ^d   Manley, Susan E ^e   Safirstein, Robert ^f  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b EUROPEAN COMMISSION   (Belgium)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SANOFI   (France)

^e RADCLIFFE INFIRMARY   (United Kingdom)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DIAGNOSTIC VALUE; ENVIRONMENTAL EXPOSURE; HUMAN; KIDNEY FAILURE; MEDICAL RESEARCH; NEPHROTOXICITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL;

EID: 8544277283     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229709048693     Document Type: Conference Paper

References (33)

1. National Research Council: Biologic Markers in Urinary Toxicology. Washington. DC, National Academy Press, 19095, pp 19, 185.
2. Lash LH, Anders MW: Cytotoxicity of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J Biol Chem 261:13076-13081, 1986.
3. Lash LH, Anders MW: Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells. J Pharmacol Exp Ther 248:531-537, 1989.
4. Lash LH, Tokarz JJ. Isolation of two distinct populations of cells from rat kidney cortex and their use in the study of chemical-induced toxicity. Anal Biochem 182:271-279, 1989.
5. Lash LH, Tokarz JJ: Oxidative stress in isolated rat renal proximal and distal tubular cells. Am J Physiol 259:F338-F347, 1990.
6. Lash LH, Tokarz JJ, Woods EB: Cytotoxicity of alkylating agents in isolated rat kidney proximal tubular and distal tubular cells. Arch Biochem Biophys 286:46-56, 1991.
7. Lash LH, Woods EB, Pedrosi BM: Hypoxia and oxygen dependence of Cytotoxicity in renal proximal tubular and distal tubular cells. Biochem Pharmacol 45:191-200, 1993.
8. Lash LH, Sausen PJ, Duescher RJ, Cooley AJ, Elfarra AA: Roles of cysteine conjugate β-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. J Pharmacol Exp Ther 269:374-383, 1994.
9. Lash LH, Tokarz JJ, Woods EB: Renal cell type specificity of cephalosporin-induced cytotoxicity in suspensions of isolated proximal tubular and distal tubular cells. Toxicology 94:97-118, 1994.
10. Lash LH, Tokarz JJ, Pegouske DM: Susceptibility of primary cultures of proximal tubular and distal tubular cells from rat kidney to chemically induced toxicity. Toxicology 103:85-103, 1995.
11. Blackburn JG, Hazen-Martin DJ, Detrisac CJ, Sens DA. Electrophysiology and ultrastructure of cultured human proximal tubule cells. Kidney Int 33:508-516, 1988.
12. Genestie I, Morin JP, Vannier B, Lorenzon G: Polarity and transport properties of rabbit kidney proximal tubule cells on collagen IV-coated porous membranes. Am J Physiol 269:F22-F30, 1995.
13. Genestie I, Morin JP, Guéry C, Bode G, Lorenzon G: Morphological and biochemical characterization of primary cultures of rabbit kidney proximal tubule cells grown on collagen-IV coated Millicell-CM. In Vitro Cell Dev Biol. In press.
14. Tune BM. Renal tubular transport and nephrotoxicity of beta lactam antibiotics: structure-activity relationships. Miner Electrolyte Metab 20:221-231, 1994.
15. Ings RMJ, Reeves DS, White LO, Bax RP, By water MJ, Holt HA: The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination. J Pharmacokinet Biopharm 13:121-142, 1985.
16. Hattersley AT, Turner RC: Mutations of the glucokinase gene and Type 2 diabetes. Q J Med 86:227-232, 1993.
17. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS) 14: Association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 38:948-952, 1995.
18. UK Prospective Diabetes Study group. UK Prospective Diabetes Study (UKPDS) 15: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in non-insulin-dependent diabetes mellitus. Kidney Int 48:1907-1911, 1995.
19. Horton V, Stratton I, Zimmett P, Mackay I, Botazzo F, Lo D, Manley S, Turner RC: Autoimmune diabetes assessed by ICA, anti-GAD and DR3/4 in population based cohort of patients with NIDDM. Diabetes 44(supp 1):236A, 1995.
20. Mogensen CE: Should ACE inhibitors be used in normotensive microalbuminuric IDDM? Diabetes Review Int 3:2-61, 1995.
21. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS) 16: Overview of 6 years' therapy of Type 2 diabetes: a progressive disease. Diabetes 44:1249-1258, 1995.
22. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS) 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin dependent diabetes mellitus. Ann Int Med 124:136-145, 1996.
23. Hypertension in Diabetes Study Group: Hypertension in Diabetes Study (HDS) I: Prevalence of hypertension in newly presenting Type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertension 11:309-317, 1993.
24. Hypertension in Diabetes Study Group. Hypertension in Diabetes Study (HDS) II: Increased risk of cardiovascular complications in hypertensive Type 2 diabetic patients. J Hypertension 11:319-325, 1993.
25. Hypertension in Diabetes Study Group. Hypertension in Diabetes Study (HDS) III: Prospective study of therapy of hypertension in Type 2 diabetes patients: efficacy of ACE inhibition and beta-blockage. Diabet Med 11:773-782, 1994.
26. Fasting Hyperglycaemia Study Group: Randomized controlled trial of sulphonylurea therapy in 227 subjects with persistent fasting hyperglycaemia. Diabetes 44(supp 1):160A(586), 1995.
27. Oliver J, MacDowell M, Tracy A: The pathogenesis of acute renal failure associated with traumatic and toxic injury: renal ischemia, nephrotoxic damage and the ischemuric episode. J Clin Invest 30:1307, 1951.
28. Oberholzer M, Thiel G, Mihatsch MJ. Karyomegalic interstitial nephritis: further support for a distinct entity and evidence for a genetic defect. Am J Kidney Dis 25:242-252, 1995.
29. Godin M, Francois A, Le Roy F, Morin JP, Creppy E, Hemet J, Fillastre JP: Karyomegalic interstitial nephritis. Am J Kidney Dis. In press.
30. Vaamonde CA, Brier RT, Gouvea W, Alpert H, Kelley J, Pardo Y: Effects of duration of diabetes on the protection observed in the diabetic rat against gentamicin induced acute renal failure. Miner Electrol Metab 10:209-216, 1984.
31. Morin JP, Leclere C, Marouillat S, Monteil C: Some milestones to in vitro organ toxicity assessment: the kidney as a case study. In vitro Toxicology, 1995. In press.
32. Monteil C, Leclere C, Fillastre JP, Morin JP: Insulin and glucose impact on functional and morphological differentiation of rabbit proximal tubule cells in primary culture. Renal Physiol Biochem 16:212-221, 1993.
33. Moritz F, Marouillat S, Monteil C, Baudelot A, Fillastre JP, Bonmarchand G, Morin JP. Impact of cephaloridine on glutathione and related enzymes: comparison of in vivo and in vitro rat models. Arch Toxicol 1995. In press.